Compare ALEMBIC PHARMA with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ALEMBIC PHARMA vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ALEMBIC PHARMA TORRENT PHARMA ALEMBIC PHARMA/
TORRENT PHARMA
 
P/E (TTM) x 17.5 37.1 47.1% View Chart
P/BV x 6.9 9.4 73.9% View Chart
Dividend Yield % 0.5 0.6 84.7%  

Financials

 ALEMBIC PHARMA   TORRENT PHARMA
EQUITY SHARE DATA
    ALEMBIC PHARMA
Mar-19
TORRENT PHARMA
Mar-19
ALEMBIC PHARMA/
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs6641,964 33.8%   
Low Rs4121,245 33.1%   
Sales per share (Unadj.) Rs208.7453.4 46.0%  
Earnings per share (Unadj.) Rs31.025.8 120.2%  
Cash flow per share (Unadj.) Rs37.162.3 59.6%  
Dividends per share (Unadj.) Rs5.5017.00 32.4%  
Dividend yield (eoy) %1.01.1 96.5%  
Book value per share (Unadj.) Rs144.2279.2 51.7%  
Shares outstanding (eoy) m188.52169.22 111.4%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.63.5 72.9%   
Avg P/E ratio x17.462.2 27.9%  
P/CF ratio (eoy) x14.525.8 56.3%  
Price / Book Value ratio x3.75.7 64.9%  
Dividend payout %17.765.9 26.9%   
Avg Mkt Cap Rs m101,461271,513 37.4%   
No. of employees `000NA13.6 0.0%   
Total wages/salary Rs m7,46714,038 53.2%   
Avg. sales/employee Rs ThNM5,642.6-  
Avg. wages/employee Rs ThNM1,032.4-  
Avg. net profit/employee Rs ThNM320.9-  
INCOME DATA
Net Sales Rs m39,34776,728 51.3%  
Other income Rs m94571 16.4%   
Total revenues Rs m39,44177,299 51.0%   
Gross profit Rs m8,73619,831 44.1%  
Depreciation Rs m1,1526,177 18.7%   
Interest Rs m1845,038 3.7%   
Profit before tax Rs m7,4939,187 81.6%   
Minority Interest Rs m110-   
Prior Period Items Rs m-930-   
Extraordinary Inc (Exp) Rs m0-3,570 0.0%   
Tax Rs m1,5681,254 125.0%   
Profit after tax Rs m5,8444,363 133.9%  
Gross profit margin %22.225.8 85.9%  
Effective tax rate %20.913.6 153.3%   
Net profit margin %14.95.7 261.2%  
BALANCE SHEET DATA
Current assets Rs m19,57750,375 38.9%   
Current liabilities Rs m14,89651,653 28.8%   
Net working cap to sales %11.9-1.7 -714.4%  
Current ratio x1.31.0 134.8%  
Inventory Days Days9092 97.5%  
Debtors Days Days4568 66.4%  
Net fixed assets Rs m27,09783,648 32.4%   
Share capital Rs m377846 44.6%   
"Free" reserves Rs m26,81146,397 57.8%   
Net worth Rs m27,18847,244 57.5%   
Long term debt Rs m4,99339,129 12.8%   
Total assets Rs m47,778141,209 33.8%  
Interest coverage x41.72.8 1,476.9%   
Debt to equity ratio x0.20.8 22.2%  
Sales to assets ratio x0.80.5 151.6%   
Return on assets %12.66.7 189.5%  
Return on equity %21.59.2 232.7%  
Return on capital %23.612.3 191.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m19,45322,103 88.0%   
Fx outflow Rs m6,0655,522 109.8%   
Net fx Rs m13,38816,581 80.7%   
CASH FLOW
From Operations Rs m8,12017,981 45.2%  
From Investments Rs m-7,556-2,413 313.2%  
From Financial Activity Rs m590-13,145 -4.5%  
Net Cashflow Rs m1,1532,380 48.5%  

Share Holding

Indian Promoters % 74.1 71.5 103.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 2.9 7.0 41.3%  
FIIs % 9.1 12.6 72.2%  
ADR/GDR % 0.0 0.0 -  
Free float % 13.9 8.8 158.0%  
Shareholders   49,328 26,511 186.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ALEMBIC PHARMA With:   FDC  UNICHEM LAB  PROCTER & GAMBLE HEALTH  AJANTA PHARMA  ALEMBIC  

Compare ALEMBIC PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Flat; Wipro & Hindalco Industries Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended on a flat note.

Related Views on News

ALEMBIC PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 13.8% (Quarterly Result Update)

Jan 19, 2021 | Updated on Jan 19, 2021

For the quarter ended December 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 13.8% YoY). Sales on the other hand came in at Rs 13 bn (up 8.7% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 27.0% (Quarterly Result Update)

Oct 27, 2020 | Updated on Oct 27, 2020

For the quarter ended September 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 27.0% YoY). Sales on the other hand came in at Rs 20 bn (up 0.6% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

ALEMBIC PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 30.0% (Quarterly Result Update)

Oct 23, 2020 | Updated on Oct 23, 2020

For the quarter ended September 2020, ALEMBIC PHARMA has posted a net profit of Rs 3 bn (up 30.0% YoY). Sales on the other hand came in at Rs 15 bn (up 17.4% YoY). Read on for a complete analysis of ALEMBIC PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 48.6% (Quarterly Result Update)

Jul 31, 2020 | Updated on Jul 31, 2020

For the quarter ended June 2020, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 48.6% YoY). Sales on the other hand came in at Rs 21 bn (up 1.7% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

TORRENT PHARMA Announces Quarterly Results (3QFY20); Net Profit Up 2.0% (Quarterly Result Update)

Jan 28, 2020 | Updated on Jan 28, 2020

For the quarter ended December 2019, TORRENT PHARMA has posted a net profit of Rs 3 bn (up 2.0% YoY). Sales on the other hand came in at Rs 20 bn (down 4.1% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

More Views on News

Most Popular

India: Recovery Stalled by Vaccine Games?(The Honest Truth)

Apr 13, 2021

Ajit Dayal on how India's vaccine strategy will impact the markets.

4 Stocks to Make Your Portfolio Immune to the Second Covid Wave(Profit Hunter)

Apr 6, 2021

Rather than predicting the market, successful investing is more about preparing well and placing your bets accordingly.

An India Revival Stock I'm Bullish On...(Profit Hunter)

Apr 9, 2021

This could take India to the position of 3rd largest economy.

Why Did the Market Crash on Monday?(Fast Profits Daily)

Apr 13, 2021

In this video, I'll you what I think is the real reason behind yesterday's market crash.

A Unique Sector for Short-Term Profits(Fast Profits Daily)

Apr 12, 2021

This ignored sector could deliver big short-term profits.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

ALEMBIC PHARMA SHARE PRICE


Apr 16, 2021 (Close)

TRACK ALEMBIC PHARMA

  • Track your investment in ALEMBIC PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ALEMBIC PHARMA

ALEMBIC PHARMA 8-QTR ANALYSIS

COMPARE ALEMBIC PHARMA WITH

MARKET STATS